Jonathan Wingfield

Biog:
Since joining AstraZeneca's Oncology department in 2000 I have worked to build secondary screening capabilities within AZ. I have focused on landing new technologies such as acoustic dispensing. In 2008 my team received the Microsoft Innovation in Pharma award for deployment of a LIMS to support SAR screening. Currently areas of interest include the application of Mass Spectrometry in H2L and applications for Nanotechnology in drug discovery.